Stem cell survival after transplantation impacted by melatonin pre-treatment

From Stroke News From Medical News Today
July 24, 2013 - 4:00am

When melatonin, a hormone secreted by the pineal gland, was used as a pre-treatment for mesenchymal stem cells (MSCs) prior to their transplantation into the brains of laboratory animals to repair damage from stroke, researchers in China found that the stem cells survived longer after transplantation...


Share this article »  

Continue reading this article »